How Much Did Bionexo Raise?
Funding & Key Investors

Bionexo, a prominent force in the Latin American healthtech sector, has successfully secured a major strategic investment, bringing its total capital raised to $81.6M. This latest infusion of $81.6M underscores the company's pivotal role in digitizing the healthcare ecosystem. By facilitating seamless connectivity between providers and suppliers, Bionexo continues to solidify its market position as a critical infrastructure provider for the regional medical industry.

What is Bionexo?

Bionexo
SoftwareHealthcare Software

Bionexo operates as a comprehensive healthtech platform, distinguished by its integrated hospital management system, Tasy. The company serves as a digital bridge connecting hospitals, clinics, health operators, and a vast network of over 35,000 suppliers. By focusing on automation and data-driven decision-making, Bionexo enhances operational efficiency across the healthcare value chain. With a reach impacting over 90 million patients annually, the firm is instrumental in transforming fragmented medical processes into measurable, high-quality outcomes for healthcare providers and laboratories alike.

How much funding has Bionexo raised?

Bionexo has raised a total of $81.6M across 1 funding round:

2021

Private Equity

$81.6M

Private Equity (2021): $81.6M with participation from Bain Capital Tech Opportunities

Key Investors in Bionexo

Bain Capital Tech Opportunities

A specialized investment arm of Bain Capital that focuses on growth-stage technology companies, providing both capital and operational expertise to scale enterprise software solutions.

What's next for Bionexo?

With this major enterprise-level funding, Bionexo is well-positioned to accelerate its strategic expansion and deepen its technological footprint. The capital will likely be deployed to enhance the Tasy platform's capabilities, potentially integrating advanced analytics and AI-driven supply chain optimization tools. As the company scales, it remains focused on strengthening its dominance in the Latin American market, ensuring that its digital infrastructure remains the backbone of efficient, patient-centric healthcare delivery. Future growth will likely center on increasing client penetration and further automating the complex procurement cycles inherent in large-scale medical operations.

See full Bionexo company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Content & Collaboration SoftwareSoftwareBusiness ServicesCommercial Printing
Business Intelligence (BI) SoftwareSoftwareBusiness ServicesSoftware Testing
Business Intelligence (BI) SoftwareSoftwareMobile App Development
SoftwareStorage & System Management SoftwareBusiness Intelligence (BI) Software

Frequently Asked Questions Regarding Bionexo Financial Insights

What are the most recent funding rounds that Bionexo has completed, and what were the funding rounds?
Bionexo has recently completed 1 funding rounds: Private Equity on Oct 18, 2021.
What is the total amount of funding Bionexo has raised to date?
Bionexo has raised a total of $81.6M in funding to date.
How many funding rounds has Bionexo completed?
Bionexo has completed 1 funding rounds.
How much funding did Bionexo raise in its most recent funding round?
Bionexo raised $81.6M in its most recent funding round.
Who are the lead investors in Bionexo's latest funding round?
The lead investor in Bionexo's latest funding round was Bain Capital Tech Opportunities. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Bionexo's history?
The largest funding round in Bionexo's history was $81.6M.
See more information about Bionexo